NCT00772213 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Gross T, Amsler F, Ummenhofer W, Zuercher M, Regazzoni P, Jacob AL, Huegli RW, Messmer P
[Interdisciplinary emergency room management of trauma patients from the standpoint of coworkers]. Chirurg. 2005 Oct;76(10):959-66. German.
Gross T, Messmer P, Amsler F, Füglistaler-Montali I, Zürcher M, Hügli RW, Regazzoni P, Jacob AL
Impact of a multifunctional image-guided therapy suite on emergency multiple trauma care. Br J Surg. 2010 Jan;97(1):118-27. doi: 10.1002/bjs.6842.
Messmer P, Jacob AL, Fries E, Gross T, Suhm N, Steinbrich W, Frede KE, Schneider T, Regazzoni P
[Technology integration and process management. Concept and implementation of a new platform for simultaneous diagnosis and therapy of acutely ill and injured patients and for elective computer assisted surgery (CAS)]. Unfallchirurg. 2001 Oct;104(10):1025-30. German.

The Impact of a Multifunctional Image Guided Therapy Suite (MIGTS) on Emergency Multiple Trauma Care - a Controlled Clinical Pilot Study

Clinical trial NCT00772213 - References